MAPT and chronic kidney disease: Although the precise mechanisms remain to be fully elucidated, patients with chronic kidney disease (CKD) frequently present with elevated plasma Tau levels, greater cerebral Aβ and Tau burden, and impaired cognitive function, suggesting a strong link between renal function and Tau clearance capacity (153).